Preference of the inhaler device and assessment of the technique among the asthmatic and COPD patients Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011
Inhaler therapy in obstructive airways disease (OAD): prescription, compliance and technique Source: Eur Respir J 2006; 28: Suppl. 50, 57s Year: 2006
Inhaler treatment options in COPD Source: Eur Respir Rev 2005; 14: 102-108 Year: 2005
Aerosolotherapy in stable chronic obstructive pulmonary disease (COPD) – common inhalers use ability and usefulness of PIF measurement in choice of inhalers Source: Annual Congress 2007 - Managing COPD in primary care Year: 2007
Inhaler choice in primary practice Source: Eur Respir Rev 2005; 14: 117-122 Year: 2005
Lung function indices for predicting mortality in COPD Source: Eur Respir J 2013; 42: 616-625 Year: 2013
Inhaler technique and peak inspiratory flow rates in patients with acute exacerbated COPD Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007
Formoterol Aerolizer inhaler technique in patients with Asthma and COPD Source: International Congress 2017 – Pulmonary drug and devices delivery Year: 2017
COPD and asthma patients are satisfied with handling and inhalation characteristics of Soft Mist InhalerÔ (Berodual® Respimat®) Source: Eur Respir J 2006; 28: Suppl. 50, 739s Year: 2006
Formoterol turbuhaler is effective and safe as maintenance or maintenance plus reliever therapy in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 243s Year: 2002
Budesonide/formoterol in a single inhaler reduces severe and mild exacerbations in patients with moderate to severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 242s Year: 2002
Use of tiotropium Respimat Soft Mist Inhaler versus HandiHaler and mortality in patients with COPD Source: Eur Respir J 2013; 42: 606-615 Year: 2013
Comparison of inspiratory flow rates using an innovative dry powder inhaler (DPI) in patients with mild–severe asthma and severe COPD Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014
Inhaler preferences and satisfaction of asthma and COPD patients Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018
Extrafine triple therapy in patients with asthma and persistent airflow limitation Source: Eur Respir J, 56 (3) 2000476; 10.1183/13993003.00476-2020 Year: 2020
New soft mist inhaler is effective and easy to use in patients with asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 338s Year: 2005
Tiotropium + olodaterol in patients with moderate to severe COPD with chronic bronchitis and/or emphysema Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016
Investigating inhaler technique in patients with COPD using different aids Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019
How frequent is bronchodilator reversibility in patients with stable asthma bronchiale and chronic obstructive lung disease (COPD) receiving maintenance therapy? Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012